StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a research report report published on Tuesday. The brokerage issued a sell rating on the stock.
Separately, Craig Hallum raised Streamline Health Solutions to a strong-buy rating in a research note on Thursday, September 5th.
Get Our Latest Stock Report on STRM
Streamline Health Solutions Price Performance
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last issued its quarterly earnings data on Wednesday, September 11th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%. The company had revenue of $4.48 million for the quarter.
Institutional Investors Weigh In On Streamline Health Solutions
A hedge fund recently bought a new stake in Streamline Health Solutions stock. Mesirow Financial Investment Management Inc. bought a new stake in shares of Streamline Health Solutions, Inc. (NASDAQ:STRM – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 123,900 shares of the company’s stock, valued at approximately $59,000. Mesirow Financial Investment Management Inc. owned about 0.21% of Streamline Health Solutions as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 31.74% of the company’s stock.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Featured Stories
- Five stocks we like better than Streamline Health Solutions
- The Most Important Warren Buffett Stock for Investors: His Own
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Ride Out The Recession With These Dividend Kings
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Overbought Stocks Explained: Should You Trade Them?
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.